What is the market doing?
What the tape says about MBX
MBX Biosciences, Inc. is +333% over the past year while the S&P 500 is +20%: 312 points ahead of the market.
+333%
1-year return · S&P 500 +20%
- vs 200-day average
- +64%
vs 200-day average · a clear uptrend
- RSI (14)
- 36
RSI (14) · neutral
- Below its 52-week high
- 11%
Below its 52-week high
Details›
- Last close2026-09-08
- $63.04
- 1 monthS&P 500 −0.30%
- −5.9%
- 1 yearS&P 500 +20%
- +333%
- vs 50-day average$58.26
- +8.2%
- 52-week high
- $70.67
- 52-week low
- $9.74
- Annualised volatility
- 116%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $501K
| Year | Return |
|---|---|
| 2026 (year to date) | +100% |
| 2025 | +71% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 2 | 1 of 2 | −14% |
| Feb | 2 | 0 of 2 | −7.9% |
| Mar | 2 | 0 of 2 | −16% |
| Apr | 2 | 2 of 2 | +22% |
| May | 2 | 2 of 2 | +11% |
| Jun | 2 | 1 of 2 | +26% |
| Jul | 2 | 2 of 2 | +18% |
| Aug | 2 | 2 of 2 | +8.2% |
| Sep | 2 | 2 of 2 | +9.2% |
| Oct | 2 | 1 of 2 | +6.8% |
| Nov | 2 | 1 of 2 | +23% |
| Dec | 2 | 0 of 2 | −9.0% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.